-

Flatiron Health Joins Veeva’s Product Partner Program to Accelerate Oncology Clinical Research

Partnership enhances oncology clinical trial efficiency through streamlined technology integration and long-term strategic collaboration.

NEW YORK--(BUSINESS WIRE)--Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, today announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry. As part of the partnership, Flatiron Health will join the Veeva Product Partner Program.

Flatiron and Veeva customers utilizing Flatiron Clinical Pipe™ will benefit from accelerated deployment and continually optimized configurations, ensuring seamless performance and a well-supported experience to meet evolving needs.

Share

This collaboration builds on the integration of Flatiron Clinical Pipe™ and Veeva EDC (Electronic Data Capture), enhancing value and experience for both research sites and sponsor customers. As a cutting-edge EHR-to-EDC connector, Flatiron Clinical Pipe™ eliminates manual data entry of structured and unstructured data—improving site workflows, lowering data monitoring costs, and accelerating study timelines. Through this partnership, Flatiron and Veeva customers utilizing Flatiron Clinical Pipe™ will benefit from accelerated deployment and continually optimized configurations, ensuring seamless performance and a well-supported experience to meet evolving needs.

“Our collaboration with Veeva strengthens Flatiron’s ecosystem of partners in clinical research, reinforcing our position as an innovator in the use of technology to streamline clinical trials,” said Alex Deyle, General Manager of Clinical Research at Flatiron Health. “Flatiron Clinical Pipe, integrated with Veeva EDC, enables more streamlined data acquisition for clinical trials across a broader set of both research sites and sponsors—ultimately reducing burden, driving operational efficiencies, and accelerating research timelines.”

Additionally, the partnership establishes a long-term forum for strategic collaboration, allowing both companies to align on future innovations that streamline clinical trial data acquisition and drive greater value for customers.

Research published in the journal ESMO Real World Data and Digital Oncology, found that clinical research teams using Flatiron Clinical Pipe™ were able to accurately transfer thousands of data points, representing completion of hundreds of case report forms (CRF), with the average time of 37 seconds for a user to launch, complete, and submit a CRF, representing significant time savings for data entry over the course of a trial.1 Data transferred to the EDC with Flatiron Clinical Pipe™ completely mirrors source data in the EHR, reducing the need for source data verification on transferred data, allowing for greater efficiency for study teams.

About Flatiron Health
Flatiron Health is a healthtech company expanding the possibilities for point of care solutions in oncology and using data for good to power smarter care for every person with cancer. Through machine learning and AI, real-world evidence, and breakthroughs in clinical trials, we continue to transform patients’ real-life experiences into knowledge and create a more modern, connected oncology ecosystem. Flatiron Health is an independent affiliate of the Roche Group. Flatiron.com @FlatironHealth

  1. Utility of automated data transfer for cancer clinical trials and considerations for implementation. Pfeffer, M. et al. ESMO Real World Data and Digital Oncology, Volume 7, 100112. DOI: 10.1016/j.esmorw.2025.100112

 

Contacts

Flatiron Health
Nina Toor
press@flatiron.com

Flatiron Health

Details
Headquarters: New York, NY
CEO: Carolyn Starrett
Employees: 2,500
Organization: PRI

Release Versions

Contacts

Flatiron Health
Nina Toor
press@flatiron.com

Social Media Profiles
More News From Flatiron Health

Flatiron Health Announces 18 Research Acceptances Featuring Flatiron's Real-World Data to Be Presented at ISPOR 2026

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the ISPOR—The Professional Society for Health Economics and Outcomes Research Annual Meeting happening from May 17-20, 2026, in Philadelphia, Pennsylvania. Flatiron's high-quality real-world data and innovative research capabilities are featured across 18+ research acceptances, including seven Flatiron authored research posters as well as a panel presentation “Beyond Black Boxes: Transparent, Validated LLM Workflows for...

Flatiron Health Publishes First Peer-Reviewed Validation Framework for AI-Extracted Real-World Oncology Data in Journal of Clinical Oncology

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced the publication of the Validation of Accuracy for LLM/ML-Extracted Information and Data (VALID) Framework in the Journal of Clinical Oncology Clinical Cancer Informatics. The framework represents the first and most comprehensive, peer-reviewed approach to evaluating the quality and reliability of real-world data extracted by large language models (LLMs) and machine learning—setting a methodological benchmark for data integrity in oncolo...

Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions

NEW YORK--(BUSINESS WIRE)--Flatiron Health today announced its presence at the American Society of Genitourinary Cancers Symposium happening from February 26-28, 2026, in San Francisco, California. Flatiron's real-world data and research capabilities are featured across multiple presentations, including 6 research acceptances spanning genitourinary cancers. A cornerstone of Flatiron’s presence at ASCO GU 2026 is the global prostate cancer and bladder cancer Panoramic datasets, which draw from o...
Back to Newsroom